1. 2009
  2. Decreased expression of vGLUT1 increases vulnerability to seizures.

    Schallier, A., Massie, A., Loyens, E., Moechars, D., Michotte, Y. & Smolders, I. J., Oct 2009, Belgisch Genootschap voor Fundamentele en Klinische Fysiologie en Farmacologie.

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)

  3. vGLUT2 heterozygous mice show more susceptibility to clonic seizures induced by pentylenetetrazol

    Schallier, A., Massie, A., Loyens, E., Moechars, D., Drinkenburg, W., Michotte, Y. & Smolders, I. J., 1 Jul 2009, In : Amino Acids. 37, s1, p. s126-s127

    Research output: Contribution to journalMeeting abstract (Journal)

  4. vGLUT2 heterozygous mice are more susceptible to clonic seizures induced by pentylenetetrazol

    Schallier, A., Massie, A., Loyens, E., Moechars, D., Drinkenburg, W., Michotte, Y. & Smolders, I. J., 14 May 2009, Belgisch Genootschap voor Farmaceutische Wetenschappen (Blankenberge).

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)

  5. vGLUT2 heterozygous mice are more susceptible to clonic seizures induced by pentylenentetrazol

    Schallier, A., Massie, A., Loyens, E., Moechars, D., Drinkenburg, W., Michotte, Y. & Smolders, I. J., 7 Mar 2009, Belgian society for physiology and pharmacology (Gent, Belgium).

    Research output: Chapter in Book/Report/Conference proceedingConference paper

  6. Altered striatal glutamate transporter functioning could explain aberrant glutamatergic neurotransmission in striatum of hemi-Parkinson rat model

    Massie, A., Goursaud, S., Schallier, A., Vermoesen, K., Hermans, E., Arckens, L., Meshul, C. & Michotte, Y., 2009, In : Amino Acids. 37, p. 126-126 1 p.

    Research output: Contribution to journalConference paper

  7. Characterization Of Preclinical Biomarkers For Epileptogenesis

    Vermoesen, K., Clinckers, R., Massie, A., Michotte, Y. & Smolders, I. J., 2009, Dag van het Farmaceutisch Instituut Mechelen 2009.

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)

  8. 2008
  9. The possible involvement of the glutamate transporters in the APP23

    Schallier, A., Massie, A., Van Dam, D., De Deyn, P. P., Michotte, Y. & Smolders, I. J., Nov 2008, Washington, Society for neuroscience.

    Research output: Chapter in Book/Report/Conference proceedingConference paper

  10. In vivo study of the neuroprotective effects of candesartan against 6-hydroxydopamine induced neurotoxicity

    Mertens, B., Massie, A., Varcin, M., Michotte, Y. & Sarre, S., Oct 2008, In : Acta Neurologica Belgica. 108, p. 78 1 p.

    Research output: Contribution to journalConference paper

  11. The possible involvement of the glutamate transporters in the APP23 transgenic mouse model for Alzheimer’s disease

    Schallier, A., Massie, A., Van Dam, D., De Deyn, P. P., Michotte, Y. & Smolders, I. J., Oct 2008, Oostende, Belgian Brain Council.

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)

ID: 164056